| Literature DB >> 32819288 |
Shiho Kosaka1, Yuki Ohara2, Shotaro Naito3, Soichiro Iimori3, Hiroshi Kado4, Tsuguru Hatta4, Masaaki Yanishi5, Shinichi Uchida3, Makoto Tanaka6.
Abstract
BACKGROUND: Chronic kidney disease (CKD) involves many factors that can cause frailty and oral hypofunction. We aimed to investigate the prevalence of frailty and oral hypofunction and to examine the associations among kidney function, frailty, and oral function in adults with CKD in Japan.Entities:
Keywords: Chronic kidney disease; Frailty; Kidney function; Oral function
Year: 2020 PMID: 32819288 PMCID: PMC7441609 DOI: 10.1186/s12882-020-02019-w
Source DB: PubMed Journal: BMC Nephrol ISSN: 1471-2369 Impact factor: 2.388
Participant characteristics according to frailty (N = 109)
| Overall | Robust + pre-frail (non-frail) ( | Frail ( | |||
|---|---|---|---|---|---|
| Sex (male), n (%) (a) | 72 (66.1) | 54 (69.2) | 18 (58.1) | 0.267 | |
| Age, median (IQR) (b) | 71 (66–79) | 71 (66–78) | 78 (69–85) | 0.004 | |
| BMI, mean ± SD (c) | 23.8 ± 3.9 | 24.3 ± 3.7 | 22.7 ± 4.0 | 0.039 | |
| CKD stage, n (%) (a) | 3a | 17 (15.6) | 15 (19.2) | 2 (11.8) | 0.167 |
| 3b | 35 (32.1) | 27 (34.6) | 8 (22.9) | ||
| 4 | 40 (36.7) | 26 (33.3) | 14 (35.0) | ||
| 5 | 17 (15.6) | 10 (12.8) | 7 (41.2) | ||
| Blood chemistry, mean ± SD, median (IQR) | eGFR (ml/min/1.73 m2) (c) | 29.8 ± 13.1 | 31.6 ± 13.1 | 25.2 ± 12.2 | 0.02 |
| Haemoglobin (g/dL) (c) | 12.4 ± 1.7 | 12.6 ± 1.6 | 11.9 ± 1.8 | 0.036 | |
| Albumin (g/dL) (b) | 3.9 (3.6–4.1) | 3.9 (3.6–4.1) | 3.9 (3.6–4.1) | 0.788 | |
| Triglyceride (mg/dL) (b) | 121.0 (98.0–176.0) | 119.0 (104.5–176.8) | 126.0 (104.5–176.8) | 0.644 | |
| Blood glucose (mg/dL) (b) | 106.0 (92.0–128.0) | 106.0 (91.8–128.8) | 110.0 (93.3–128.3) | 0.724 | |
| Primary kidney disease, n (%) (a) | Glomerulonephritis | 24 (22.0) | 19 (24.4) | 5 (16.1) | 0.582 |
| Diabetic nephropathy | 19 (17.4) | 13 (16.7) | 6 (19.4) | ||
| Polycystic kidney disease | 1 (0.9) | 1 (1.3) | 0 | ||
| Nephrosclerosis | 35 (32.1) | 22 (28.2) | 13 (41.9) | ||
| Others | 30 (27.5) | 23 (29.5) | 7 (22.6) | ||
| Comorbidity, n (%) (a) | Diabetes Mellitus | 38 (34.5) | 24 (30.8) | 14 (45.2) | 0.155 |
| Hypertension | 75 (68.2) | 55 (70.5) | 20 (64.5) | 0.542 | |
| Hyperlipidaemia | 38 (34.5) | 29 (37.2) | 9 (29.0) | 0.421 | |
| Cardiovascular disease | 24 (22.0) | 14 (17.9) | 10 (32.3) | 0.104 | |
| Cerebrovascular disease | 8 (7.3) | 5 (6.4) | 3 (9.7) | 0.555 | |
| Hyperuricemia | 25 (22.7) | 18 (23.1) | 7 (22.6) | 0.956 | |
| Osteoporosis | 2 (1.8) | 1 (1.3) | 1 (3.2) | 0.495 | |
| Oral function, mean ± SD or median (IQR) | ODK (pa)/sec (b) | 6.0 (4.8–6.7) | 6.2 (5.6–6.8) | 5.3 (4.4–6.5) | 0.004 |
| ODK (ta)/sec (b) | 5.8 (4.9–6.4) | 6.0 (5.2–6.7) | 4.9 (4.0–6.1) | 0.001 | |
| ODK (ka)/sec (b) | 5.2 (4.0–6.0) | 5.6 (4.2–6.2) | 4.3 (3.6–5.9) | 0.027 | |
| Mastication ability (c) | 150.0 ± 61.5 | 156.9 ± 58.4 | 132.2 ± 66.6 | 0.062 | |
| RSST number of times (b) | 2.0 (1.0–4.0) | 2.5 (1.0–4.3) | 1.5 (0–3.0) | 0.029 | |
| Tooth condition, median (IQR) (b) | Number of teeth | 22.0 (9.0–26.0) | 23.0 (13.5–27.0) | 15.5 (7.8–25.3) | 0.11 |
| Functional teeth | 28.0 (25.0–28.0) | 28.0 (25.0–28.0) | 25.5 (21.0–28.0) | 0.015 | |
Data are expressed as mean ± standard deviation or median (inter-quartile range), and compared by χ square testa, Mann-Whitney U testb, and unpaired t-testc. ODK Oral diadochokinesis, RSST Repetitive saliva swallowing test
Descriptive statistics for oral function by CKD stage (N = 109)
| Overall | Stage 3a | Stage 3b | Stage 4 | Stage 5 | |||
|---|---|---|---|---|---|---|---|
| Oral function, mean ± SD or median (IQR) | ODK (pa)/sec | 6.0 (4.8–6.7) | 6.2 (5.8–6.7) | 6.0 (4.8–6.8) | 6.2 (4.8–6.9) | 5.4 (3.5–6.3) | 0.113 |
| ODK (ta)/sec | 5.8 (4.9–6.4) | 6.0 (5.2–6.5) | 5.6 (5.1–6.3) | 5.9 (4.9–6.6) | 5.6 (4.7–6.2) | 0.386 | |
| ODK (ka)/sec | 5.2 (4.0–6.0) | 5.6 (4.4–6.0) | 5.5 (4.0–6.1) | 5.2 (3.9–6.2) | 5.0 (3.6–6.2) | 0.459 | |
| Mastication ability | 150.0 ± 61.5 | 166.0 ± 67.5 | 153.0 ± 66.0 | 142.7 ± 55.0 | 140.1 ± 62.2 | 0.161 | |
| RSST number of times | 2.0 (1.0–4.0) | 2.4 ± 1.8 | 2.7 ± 2.1 | 2.9 ± 2.5 | 2.1 ± 1.4 | 0.746 | |
| Tooth condition, median (IQR) | Number of teeth | 22.0 (9.0–26.0) | 24.5 (15.8–26.0) | 21.0 (6.0–26.0) | 22.0 (9.8–28.0) | 22.0 (10.5–27.0) | 0.916 |
| Functional teeth | 28.0 (25.0–28.0) | 27.0 (24.0–28.0) | 28.0 (25.8–28.0) | 28.0 (23.0–28.0) | 27.0 (24.0–28.0) | 0.717 | |
Jonckheere-Terpstra trend test
ODK Oral diadochokinesis, RSST Repetitive saliva swallowing test
Associations among frailty, kidney function, and oral function
| Parameters | Odds ratio | 95% Confidence interval | |
|---|---|---|---|
| eGFR | 0.96 | 0.92–1.00 | 0.048 |
| ODK (ta)/sec | 0.68 | 0.47–0.98 | 0.038 |
| Mastication ability | 1.00 | 0.99–1.01 | 0.889 |
| RSST number of times | 0.76 | 0.57–1.01 | 0.056 |
| Age | 1.05 | 0.99–1.11 | 0.097 |
| Sex | 0.73 | 0.26–2.02 | 0.541 |
| BMI | 0.92 | 0.80–1.06 | 0.263 |
Binary logistic regression analysis
ODK Oral diadochokinesis, RSST Repetitive saliva swallowing test